Skip to main content
A potent oral P-selectin blocking agent improves microcirculatory blood flow and a marker of endothelial cell injury in patients with sickle cell disease.
Iron chelation adherence to deferoxamine and deferasirox in thalassemia.
Hemoglobin H-constant spring in North America: an alpha thalassemia with frequent complications.
HLA type and risk of alloimmunization in sickle cell disease.
Hydroxycarbamide-induced changes in E/beta thalassemia red blood cells.
Clinical application of deferasirox: practical patient management.
Pyrimethamine treatment does not ameliorate lymphoproliferation or autoimmune disease in MRL/lpr-/- mice or in patients with autoimmune lymphoproliferative syndrome.
Morbidity and mortality in chronically transfused subjects with thalassemia and sickle cell disease: A report from the multi-center study of iron overload.
Pulmonary hypertension in thalassemia: association with platelet activation and hypercoagulable state.
Fluorodeoxyglucose positron emission tomography (FDG-PET) for monitoring lymphadenopathy in the autoimmune lymphoproliferative syndrome (ALPS).